Federal Advocacy Priorities
Fight Colorectal Cancer is on the ground in Washington, D.C., educating policymakers and ensuring that the colorectal cancer community is represented when and where policy is created.
The Removing Barriers to Colorectal Cancer Screening Act
H.R. 1570/S. 668, the so-called “Medicare loophole bill” would waive coinsurance for Medicare patients who undergo a colonoscopy and have polyps removed – making it easier for more seniors to get screened for colorectal cancer, saving lives and money.
Funding for the National Institutes of Health (NIH) and National Cancer Institute (NCI)
Research takes time and resources. The NIH and NCI need increased and predictable federal investment to continue the development of new treatments and cures for those with colorectal cancer.
Funding for the Department of Defense Peer-Reviewed Cancer Research Program
The Peer-Reviewed Cancer Research Program funds innovative, high-impact medical research for cancer prevention, detection, treatment and survivorship for 15 different cancer types, including colorectal cancer. Eligibility of colorectal cancer to receive research funding under the program is not guaranteed – we must advocate for it’s inclusion every year.
Funding for the Centers for Disease Control and Prevention Colorectal Cancer Control Program
The Colorectal Cancer Control Program partners with state health departments, universities and tribal organizations to implement evidence-based programs to increase screening, particularly in underserved communities.
Other Issues We Care About
Oral Chemotherapy Parity
Access to Clinical Trials
Access to Biomarker Testing
Young Adult Cancer Survivorship Issues
Prevention & Screening
Access to Care
Quality of Care
Medicare and Medicaid
Pre-existing Conditions Protections
Annual & Lifetime Coverage Caps
State Advocacy Priorities
With advocates across the country, we can be on the ground advocating for policies that will increase access to colorectal cancer screening in every community. Learn about the state advocacy priorities we are currently monitoring.